An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
StatPearls [Internet].
Treasure Island (FL): StatPearls Publishing; 2025 Jan-.
Top results in this bookTable of Contents
DNA Mismatch Repair Deficiency Tumour Testing for Patients With Colorectal Cancer: A Health Technology Assessment [Internet].
Assasi N, Blackhouse G, Campbell K, et al.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2016 Aug. (CADTH Optimal Use Report, No. 5.3b.)
Madame Curie Bioscience Database [Internet].
Austin (TX): Landes Bioscience; 2000-2013.
Molecular testing for Lynch syndrome in people with colorectal cancer: systematic reviews and economic evaluation.
Snowsill T, Coelho H, Huxley N, et al.
Southampton (UK): NIHR Journals Library; 2017 Sep. (Health Technology Assessment, No. 21.51.)
Holland-Frei Cancer Medicine. 6th edition.
Kufe DW, Pollock RE, Weichselbaum RR, et al., editors.
Hamilton (ON): BC Decker; 2003.
World Cancer Report: Cancer research for cancer prevention.
Wild CP, Weiderpass E, Stewart BW, editors.
Lyon (FR): International Agency for Research on Cancer; 2020.
Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
Stinton C, Jordan M, Fraser H, et al.
Southampton (UK): NIHR Journals Library; 2021 Jun. (Health Technology Assessment, No. 25.42.)
Pembrolizumab (Keytruda): Therapeutic area: Unresectable or metastatic microsatellite instability-high or mismatch repair deficient solid tumours: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 May.
Pembrolizumab in Combination With Lenvatinib (Keytruda and Lenvima): CADTH Reimbursement Review: Therapeutic area: Advanced endometrial cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Dec.
A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome.
Snowsill T, Huxley N, Hoyle M, et al.
Southampton (UK): NIHR Journals Library; 2014 Sep. (Health Technology Assessment, No. 18.58.)
Genomes. 2nd edition.
Brown TA.
Oxford: Wiley-Liss; 2002.
Evaluating the Taxonomic Status of the Mexican Gray Wolf and the Red Wolf.
National Academies of Sciences, Engineering, and Medicine; Division on Earth and Life Studies; Board on Agriculture and Natural Resources; Board on Life Sciences; Committee on Assessing the Taxonomic Status of the Red Wolf and the Mexican Gray Wolf.
Washington (DC): National Academies Press (US); 2019 Mar 28.
Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet].
York (UK): Centre for Reviews and Dissemination (UK); 1995-.
GeneReviews® [Internet].
Adam MP, Bick S, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2026.
Dostarlimab (Jemperli): Therapeutic area: endometrial cancer, in combination with carboplatin and paclitaxel: CADTH Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2024 Jul.
Pembrolizumab (Keytruda): CADTH Reimbursement Review: Therapeutic area: Advanced endometrial cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Apr.
Mismatch Repair Deficiency Testing for Patients with Colorectal Cancer: A Clinical and Cost-Effectiveness Evaluation [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2015 Sep. (CADTH Optimal Use Report, No. 5.3a.)
Dostarlimab (Jemperli): CADTH Reimbursement Review: Therapeutic area: Endometrial cancer [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Nov.
Assay Guidance Manual [Internet].
Markossian S, Grossman A, Baskir H, et al., editors.
Bethesda (MD): Eli Lilly & Company and the National Center for Advancing Translational Sciences; 2004-.
Dostarlimab (Jemperli): Therapeutic area: Endometrial cancer: Reimbursement Review [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2025 Oct.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on